**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 74-96-4 |Bromoethane | 98% | 200-825-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN F
Risk Phrases: 11 20/22 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Highly flammable. Harmful by inhalation and if swallowed. Limited
evidence of a carcinogenic effect.Water-reactive.Carcinogen.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Exposure may cause irritation characterized
by redness, dryness, and inflammation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause respiratory failure. May cause systemic toxic
effects on the heart, liver, and kidneys.
Inhalation:
Causes respiratory tract irritation. Irritation may lead to chemical
pneumonitis and pulmonary edema. May cause effects similar to those
described for ingestion. Causes narcotic effects including headache,
dizziness, weakness, unconsciousness, and possible death.
Chronic:
Prolonged or repeated skin contact may cause irritation. Chronic
inhalation and ingestion may cause effects similar to those of acute
inhalation and ingestion. May cause cancer in humans.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use carbon dioxide or dry chemical. DO NOT USE WATER!
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Clean up spills immediately,
observing precautions in the Protective Equipment section. Scoop up
with a nonsparking tool, then place into a suitable container for
disposal.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Wash hands before eating. Remove
contaminated clothing and wash before reuse. Use only in a
well-ventilated area. Keep away from heat, sparks and flame. Do not
get on skin or in eyes. Do not ingest or inhale.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a cool, dry place. Store in a tightly closed
container. Keep away from water.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels below recommended
exposure limits.
Exposure Limits
CAS# 74-96-4:
United States OSHA: 200 ppm TWA; 890 mg/m3 TWA
Belgium - TWA: 5 ppm VLE; 22 mg/m3 VLE
France - VME: 200 ppm VME; 890 mg/m3 VME
Malaysia: 5 ppm TWA; 22 mg/m3 TWA
Netherlands: 5 ppm MAC; 22 mg/m3 MAC
Russia: 5 mg/m3 TWA
Spain: 5 ppm VLA-ED; 23 mg/m3 VLA-ED
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: Perceptible odor @ 200 ppm.
pH: Not available.
Vapor Pressure: 400 mm Hg @ 20 C
Viscosity: Not available.
Boiling Point: 38.4 deg C
Freezing/Melting Point: -119 deg C
Autoignition Temperature: 952 deg F ( 511.11 deg C)
Flash Point: -4 deg F ( -20.00 deg C)
Explosion Limits, lower: 6.7
Explosion Limits, upper: 11.3
Decomposition Temperature: Not available.
Solubility in water: Slightly soluble in water.
Specific Gravity/Density: 1.45
Molecular Formula: C2H5Br
Molecular Weight: 108.939
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
High temperatures, mechanical shock, incompatible materials, ignition
sources, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong bases, strong oxidizers, magnesium, and water.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 74-96-4: KH6475000
LD50/LC50:
CAS# 74-96-4: Inhalation, mouse: LC50 = 16230 ppm/1H; Inhalation,
mouse: LC50 = 36000 mg/m3/2H; Inhalation, rat: LC50 = 26980 ppm/1H;
Inhalation, rat: LC50 = 534000 mg/m3/4H; Oral, rat: LD50 = 1350
mg/kg.
Carcinogenicity:
Bromoethane -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
California: carcinogen, initial date 12/22/00
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: ETHYL BROMIDE
Hazard Class: 6.1
UN Number: 1891
Packing Group: II
IMO
Shipping Name: ETHYL BROMIDE
Hazard Class: 6.1
UN Number: 1891
Packing Group: II
RID/ADR
Shipping Name: ETHYL BROMIDE
Hazard Class: 6.1
UN Number: 1891
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN F
Risk Phrases:
R 11 Highly flammable.
R 20/22 Harmful by inhalation and if swallowed.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 74-96-4: 2
Canada
CAS# 74-96-4 is listed on Canada's DSL List.
CAS# 74-96-4 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 74-96-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
l-Cysteic Acid Monohydrate, 99+%
| 23537-25-9 |
|
1-Hexanesulfonic acid sodium salt premixed concentrate
| |
|
N-Alpha-Carbobenzyloxy-L-Asparagine, 98%
| 2304-96-3 |
|
Ytterbium atomic absorption standard solution, 1 mg/ml yb in 2% hno3
| |
|
Bromotrichloromethane, 99%
| 75-62-7 |
|
Dicyclopentadiene, 95%, stabilized with 100-200 ppm
| 77-73-6 |
|
3-Amino-1-propanesulfonic acid, 95%
| 3687-18-1 |
|
Copper(ii) fluoride, anhydrous, 99+%
| 7789-19-7 |
|
2-Chloro-4-Fluorophenylacetic Acid
| 177985-32-9 |
|
Cyclopropyl Phenyl Sulfide
| 14633-54-6 |
|
BOC-L-Tyrosine, 99+%
| 3978-80-1 |
|
1,8-Octanediol, 99+%
| 629-41-4 |
|
3-Thiophenecarboxylic acid, 99%
| 88-13-1 |
|
1,2,3-Trimethylbenzene, Tech., 90%
| 526-73-8 |
|
Molybdenum(v) chloride, 98%
| 10241-05-1 |
|
2-Dimethylaminoethyl Acetate
| 1421-89-2 |
|
4-Benzyl-4-Hydroxypiperidine, 95+%(GC)
| 51135-96-7 |
|
8-Chloroquinoline, 99% (gc)
| 611-33-6 |
|
2-Ethyl-3,5(6)-dimethylpyrazine,99.5+%
| 27043-05-6 |
|
p-Ethoxybenzyl Alcohol, 98%
| 6214-44-4 |
|
2,3-Dichlorothiophene, 97%
| 17249-79-5 |
|
Tropolone, 98%
| 533-75-5 |
|
1,3-Difluorobenzene, 99+%
| 372-18-9 |
|
2-Methylundecanal, 95%
| 110-41-8 |
|
2-Ethyl-2-methyl-1,3-dioxolane, 99%
| 126-39-6 |
|
Bromoethane, 98%
| 74-96-4 |
|
1,3,5-Triphenylbenzene, 97%
| 612-71-5 |
|
1-Tetradecene, 92%
| 1120-36-1 |
|
9,10-Anthracenedicarboxaldehyde, 95% (UV-Vis)
| 7044-91-9 |
|
Lead cyclohexanebutyrate
| 62637-99-4 |
|
1-Butanethiol, 99+%
| 109-79-5 |
|
L-(+)-Homoarginine hydrochloride, 99+%
| 1483-01-8 |
|
3,4-(Methylenedioxy)-aniline, 97%
| 14268-66-7 |
|
(2-Chloroethyl)benzene, 99%
| 622-24-2 |
|
Poly(propylene), chlorinated
| 68442-33-1 |
|
Dodecyl aldehyde, 96%, stabilized with 0.1% BHA
| 112-54-9 |
|
N,N'-Diallyltartardiamide
| 58477-85-3 |
|
5,6,7,8-Tetrahydro-2-naphthol, 98%
| 1125-78-6 |
|
Cyclodecanone, 97%
| 1502-06-3 |
|
4-Amino-1-butanol, 98%
| 13325-10-5 |
|
4-Aminoveratrole, 98%
| 6315-89-5 |
|
2-Bromo-4-nitrotoluene, 98%
| 7745-93-9 |
|
Pulegone (Pract), 88% (GC)
| 89-82-7 |
|
Diethyl suberate, 98%
| 2050-23-9 |
|
beta-Bromostyrene, mixture of cis/trans isomers, 97%
| 103-64-0 |
|
Naphthenic acids (pract)
| 1338-24-5 |
|
S(+)-1,3-Butanediol, 98%
| 24621-61-2 |
|
5-Bromo-1,2,4-trimethylbenzene, 99%
| 5469-19-2 |
|
alpha-D(+)-Melibiose hydrate, 99+%
| 585-99-9 |
|
O-Tolualdehyde 98% (Stabilized with 0.1 % H.Q.)
| 529-20-4 |
|
|